Connect with us

Cannabis News

You Can’t Make This Stuff Up

Published

on


reschudle marijuana dea vs congress

The consumption of marijuana has surged dramatically, with a notable instance in Michigan, where recreational use has recently been legalized. In its first year, marijuana sales are poised to exceed $3 billion, propelled by a remarkable performance in July.

 

This upswing can be attributed to Generation Z opting for marijuana over alcohol, considering it a healthier alternative. However, the industry faces challenges such as disorderly state enforcement, burdensome taxes, and restrictive regulations, including the absence of interstate commerce, leading to significant disruptions.

 

Lawmakers’ Push for Cannabis Reform: Urgency, Criticism, and Response

A Democratic congressman is urging the Drug Enforcement Administration (DEA) to expedite its evaluation of marijuana and adhere to the recommendation from the U.S. Department of Health and Human Services (HHS) to reclassify cannabis to Schedule III.

 

In a letter addressed to DEA Administrator Anne Milgram on Thursday, Rep. Steve Cohen (D-TN) expressed gratitude for the opportunity to discuss the scheduling review process during a House subcommittee hearing in July.

 

However, he emphasized the need for the agency to accelerate the task completion. Since the mentioned hearing, HHS has concluded its scientific assessment of cannabis, advising the DEA to move it from Schedule I to Schedule III under the Controlled Substances Act (CSA).

 

Congressman Steve Cohen strongly told the Drug Enforcement Administration (DEA) to listen to the U.S. Department of Health and Human Services (HHS) advice. He said it’s essential to speed up the DEA’s review process and quickly make new rules.

 

Cohen said that putting marijuana in Schedule I was a big mistake in the past. It led to very harsh and unfair prison sentences, especially for people of color. In a letter to DEA Administrator Anne Milgram, he talked about how this affected society, especially in marginalized communities. He also mentioned that almost half of the states had already allowed people to use marijuana for fun.

 

Cohen told Milgram directly that she can make history by making positive changes. He talked about the efforts in Congress to change the rules about marijuana and said it’s essential to fix the unfair and wrong policy. Cohen wanted Milgram to take decisive action to bring justice and fix the problems caused by the current rules on marijuana.

 

Congressman Steve Cohen strongly supports ending the federal ban on marijuana. He’s urging the Drug Enforcement Administration (DEA) to act quickly. Cohen stressed the importance of prompt action, saying, “The DEA should move as fast as possible on this, and I hope to see a proposal on this issue soon.”

 

Cohen’s stance aligns with the U.S. Department of Health and Human Services (HHS) recommendation to reclassify marijuana to Schedule III potentially. However, the Congressional Research Service (CRS) mentioned that while it’s “likely” the DEA will follow the HHS recommendation, the DEA has asserted its “final authority” in making scheduling decisions, regardless of HHS findings.

 

In a recent letter to lawmakers, the DEA clarified its role: “DEA has the final authority to schedule, reschedule, or deschedule a drug under the Controlled Substances Act, after considering relevant criteria and HHS’s evaluation.” The agency emphasized that it is conducting a thorough review before deciding on marijuana scheduling.

 

Cohen’s push for quick action reflects his belief in urgently addressing marijuana’s current Schedule I classification. The complexities between HHS recommendations and DEA authority highlight the importance of carefully evaluating scientific evidence and regulations in decision-making.

DEA’s Controversial Role in Marijuana Rescheduling: A Tug-of-War on Federal Action

Biden’s slow progress toward federal action was significantly boosted when his administration sought rescheduling last year. However, the DEA has recently stirred controversy over the issue of marijuana rescheduling. Traditionally at the forefront of the War on Drugs, the DEA has asserted its role as the ultimate decision-maker in this matter.

 

In a letter addressed to Congressman Earl Blumenauer, Michael Miller, who is currently acting as the Chief of the Office of Congressional Affairs at the DEA, shed light on the ongoing examination of potentially reclassifying marijuana. This entire process was set in motion following a directive from President Biden in October 2022.

 

The initial step involved a scientific evaluation carried out by the Department of Health and Human Services (HHS), which recommended the reclassification of marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).

 

This recommendation surfaced in August. Subsequently, the DEA is now conducting a thorough review of the situation, as outlined in the letter that was reported by Punchbowl News just last month. This dual-layered examination process is part of the broader initiative to understand and potentially modify the current scheduling of marijuana within the regulatory framework.

 

According to the DEA, they hold the ultimate decision-making power to schedule, reschedule, or deschedule a drug according to the Controlled Substances Act. They explain that the decision was made after considering relevant statutory and regulatory criteria and the scientific and medical evaluation conducted by the Department of Health and Human Services (HHS). Currently, the DEA is actively conducting its comprehensive review.”

Presidential Influence and Policy Impact

President Joe Biden issued an executive order in October 2022 asking federal cabinet-level bodies to reassess marijuana’s legal categorization in the United States. This action served as the impetus for the possible rescheduling of marijuana.

 

In response to Biden’s order, the Department of Health and Human Services suggested on August 29 that the DEA take into consideration reclassifying marijuana from its present Schedule 1 classification to Schedule 3 within the Controlled Substances Act.

 

Significant federal tax reform for financially suffering legal cannabis companies is possible with this proposed reclassification, which may also spur additional progress on federal marijuana reform programs.

However, the DEA must carefully analyze and then formally propose a modification to federal law before any amendments can take effect. A group of Democratic governors has already requested the Biden administration to reschedule marijuana by the end of 2023.

 

Even though this request was granted, it appears that the question of marijuana rescheduling is one of when rather than if. According to a Congressional Research Service analysis, the DEA should follow the HHS proposal.

 

Amid these developments, Democratic Representative Blumenauer of Oregon stressed in a memo on Wednesday that President Biden’s chances of winning reelection this year could be improved by pushing for marijuana policy change.

 

After his legislative term ends on January 3, 2025, Blumenauer—who has long supported cannabis use and co-chairs the House’s legislative Cannabis Caucus—plans to retire.

Conclusion

The emotional call from Democratic Congressman Steve Cohen for the Drug Enforcement Administration (DEA) to promptly reassess and reclassify marijuana highlights a critical juncture in the ongoing debate over cannabis regulation. Cohen’s plea aligns with the U.S. Department of Health and Human Services (HHS) recommendation to shift marijuana to Schedule III, emphasizing the urgency of rectifying the historical misclassification that disproportionately affected marginalized communities.

 

THE DEA ON CANNABIS, READ ON…

DEA SAYS TO GROW MARIJUANA MUSHROOMS

THE DEA SAYS GROW MORE WEED AND MUSHROOMS FOR RESEARCH THIS YEAR?



Source link

Cannabis News

Is Kratom Addictive? Understanding Dependence, Risks, and Safe Usage

Published

on

By


is kratom addictive

Is kratom addictive? Discover the potential for dependence on Kratom, the risks involved with its use, and how to approach its consumption responsibly.

From 2011 to 2017, over 1,800 calls to poison centers involved kratom in the U.S. This significant number highlights the concern regarding kratom addiction.

However, without Food and Drug Administration (FDA) oversight, and due to various consumption methods like teas and capsules, there are significant health risks. Safe use of kratom is now in question due to these issues.

Research debates how dependence develops, outlining signs like loss of control and withdrawal symptoms. These signs are seen in regular kratom users. Ironically, some people switch from drugs like heroin to kratom, looking for a legal alternative.

Understanding Kratom: Origins and Prevalence

Kratom comes from the Mitragyna speciosa tree in Southeast Asia. It can act like a stimulant or like opioids, based on how much you take. People use it in different ways, for a small energy boost or stronger effects at higher doses.

The legal status of kratom in the U.S. is complicated and changing. It’s a hot topic because some worry about its misuse. It’s still legal in several states. This shows how different places handle drug rules. The National Institute on Drug Abuse is looking into its medical benefits. But, the FDA hasn’t approved it for medical use yet. The DEA calls it a “drug of concern,” which means policies might change.

  • From 2011 to 2017, poison control centers in the U.S. got over 1,800 reports about kratom. This shows it’s widely used and might pose health risks.

  • Kratom’s main ingredients bind to opioid receptors very strongly, stronger than morphine even. This fact is key to understanding its effects.

  • As more people use kratom, more are reporting serious health problems. These include liver and heart issues, and tough withdrawal symptoms, particularly in those already sick.

The statistics show mounting worries about kratom in the U.S. As its use grows, it’s becoming more important to health policies and laws. What happens next will depend on further research and legal decisions.

Is Kratom Addictive: Investigating the Substance’s Nature

The question of kratom’s addictiveness focuses on how it affects brain receptors and its long-term health implications. The ongoing debate highlights concerns about dependence and the risk of addiction. Scientists are closely looking at these issues.

How Kratom Works in the Brain

Kratom’s main alkaloids, mitragynine and 7-hydroxymitragynine, bind to the brain’s opioid receptors, similar to painkillers and narcotics. This connection suggests a potential risk of dependence. These alkaloids are key to kratom’s pain relief but also point to possible addiction concerns, especially with frequent, high-dose usage.

Patterns and Consequences of Long-term Use

  • Using kratom often, especially in large doses, can increase the risk of dependence and intense withdrawal symptoms, similar to opioid withdrawal.

  • Although some use it for pain or to improve mood, long-term kratom users might see serious health problems, like liver damage and mental health issues.

  • Withdrawal symptoms, including irritability, nausea, and sleep problems, show kratom’s impact on one’s physical and mental health.

Assessment of Addiction Risks

Studies indicate a significant risk of addiction to kratom, especially with high doses or frequent use. Dependence develops as the body gets used to kratom, leading to tolerance and a need for more to feel its effects. Withdrawal symptoms emphasize this risk, as highlighted by health experts.

Physiological Effects: Kratom’s Impact on the Body

There is a lot of debate about the safety and use of kratom. This herbal extract comes from the Mitragyna speciosa plant. It has drawn attention for its possible harmful effects on the body. The FDA has issued many warnings about kratom, raising safety concerns.

  • Kratom Adverse Effects: Kratom users have reported side effects like nausea, vomiting, and confusion. More serious issues include high blood pressure and liver damage. These problems highlight the risks of using kratom.

  • Herbal Extract Safety: Some kratom products contain heavy metals and pathogens. These can cause severe health issues, including death. This shows the importance of safety in herbal products.

  • FDA Warnings and Regulations: The FDA has linked kratom to over 35 deaths and warns against using it. They point out the lack of medical uses and the risk of addiction.

  • Physiological Impact: Kratom’s effects depend on the dose and the user’s body. Yet, it can lead to dangerous outcomes like liver damage and seizures.

  • Safety Concerns from Authorities: Federal agencies like the DEA are worried about kratom’s safety. Although not a controlled substance, monitoring suggests users should be careful.

Kratom might offer temporary relief for some ailments, but it comes with significant risks. The FDA’s warnings should make people think twice. If considering kratom, it’s crucial to talk to a doctor first. Experts stress the need for safety and caution with herbal extracts.

Conclusion

Kratom’s role in health and regulation is complex, with views and research findings widely varied. Some people use kratom for its claimed health benefits, but it’s a hot topic. Experts advise caution and suggest consulting a doctor before using kratom due to the unclear effects.

Clinical studies using scores like SOWS and COWS haven’t confirmed withdrawal symptoms from kratom. This adds to the debate, especially when some users report withdrawal. This makes kratom a controversial subject among different findings and user experiences.

When it comes to treating opioid addiction, kratom can be both helpful and harmful. Some have used it successfully to fight addiction. Yet, some states have banned it. This highlights the need for regulations and consistent product quality. It also raises questions about kratom’s legal status due to mixed actions by authorities.

The situation shows how complex kratom is in the realm of substance use and law. Without clear evidence supporting either its benefits or risks, it poses a challenge. More research is needed to guide regulations and health advice. For now, anyone thinking of using kratom should be careful, seek medical advice, and keep up with laws and health guidelines.

 

WHAT IS KRATOM ANYWAY? READ ON…

WHAT IS KRATOM

WHAT IS KRATOM AND WHY ARE YOU HEARING ABOUT IT NOW?



Source link

Continue Reading

Cannabis News

New Rule, December 5: Oregon Cannabis Retailers, Processors and Labor Peace Agreements

Published

on

By


Oregon’s Measure 119 passed last week, as expected. This means that as of December 5th, every OLCC licensed retailer, processor, researcher and testing lab must secure a labor peace agreement before OLCC will approve a new or renewal license application. The labor peace agreement must be with a “bona fide labor organization.”

I previewed M119 back in September, explaining:

Compulsory peace agreements aren’t anything new in cannabis, although it would be something different here in Oregon. California, for example, requires labor peace agreements for many of its cannabis licensees, and has for many years. We had clients struggle with the concept initially, and we saw some fumbled rollouts, but people eventually adjusted.

Measure 119 further provides that retailers and processors would be required to remain neutral, under the peace agreements, when labor organizations communicate with employees about collective bargaining rights “with any licensure or renewal application.”

M119 may be legally problematic

I’m not a First Amendment lawyer, but it’s not clear to me that an Oregon business can be constrained from speaking with employees– regardless of what M119 provides. Oregon’s speech protections are extremely broad, which is why we have a naked bike ride, tons of strip clubs and no campaign finance restrictions.

I’m also not a labor lawyer, but I’m told M119 could hit a snag on the National Labor Relations Act.

I’ve run these concepts by an Oregon First Amendment lawyer and a couple of labor lawyers, and all confirmed to me that M119 has real exposure. I found that feedback interesting, because M119 sponsors would have understood this when they set out signature gathering. Back in September, I wrote:

The United Food and Commercial Workers Local 555 spent a good deal of money to get Measure 119 on the ballot, rounding up some 163,000 signatures when only 117,173 were required. This follows on a stymied effort to get House Bill 3183 passed last year, which would have accomplished the same thing legislatively.

HB 3183 failed after a couple of advisory letters from the State of Oregon, Legislative Counsel Committee (see here and here). Those letters discussed preemption exposure for what is now M119 under the National Labor Relations Act, The Taft Hartley Act, and other federal laws. Oregon Business and Industry, the largest business group in the state, also submitted opposing testimony, highlighting legal exposure.

As to the First Amendment issues, anyone watching this is advised to follow litigation recently brought by Ctrl Alt Destroy, Inc., on a similar requirement in California.

So let’s see how that goes, and let’s see if anyone in the Oregon cannabis space wants to make a run at litigating M119. For now, credit to UFCW Local 555, I guess, for not giving up and for getting this thing on the ballot. And for having some fun by slipping a Rickroll into the voter pamphlet. I’m sure that won a few people over.

The OLCC process

I don’t have any information yet on what OLCC is going to do ahead of the December 5th deadline. It’s worth noting that, in addition to California, other recreational cannabis states including New York, New Jersey, Rhode Island, Connecticut and Delaware all have similar requirements. Most likely, OLCC will put out an FAQ page very soon that looks something like this and licensees will need to upload something or other to CAMP with respect to any post-December 5th application or renewal.

As far as OLCC licensees negotiating these agreements, the best approach would be to speak with experienced labor counsel. Labor law is highly specialized, and negotiating a labor peace agreement with any outfit claiming to be a “bona fide labor organization” is not a typical exercise.

For now, this is just one more thing for licensed cannabis businesses to comply with. Please reach out to us if you have any questions or need a referral.



Source link

Continue Reading

Cannabis News

The CBD Dog Treat Guide

Published

on

By


CBD dog treats good or bad

As the popularity of CBD (cannabidiol) continues to rise, many pet owners are exploring its potential benefits for their furry companions. CBD is derived from the hemp plant and is known for its therapeutic properties, which may help alleviate anxiety, pain, inflammation, and other health issues in dogs. However, when considering CBD treats for your dog, it’s crucial to understand the ingredients that go into these products. This article will delve into the essential ingredients to look for in CBD treats, their benefits, potential risks, and how to choose the right product for your canine friend.

 

Understanding CBD and Its Benefits for Dogs

 

Before we dive into the ingredients, it’s important to understand what CBD is and how it can benefit dogs. CBD is a non-psychoactive compound found in cannabis plants. Unlike THC (tetrahydrocannabinol), which can produce a “high,” CBD does not have intoxicating effects. Instead, it interacts with the endocannabinoid system (ECS) in both humans and animals, which plays a crucial role in regulating various physiological processes.

 

Potential Benefits of CBD for Dogs

 

  • Anxiety Relief: Many dogs experience anxiety due to various factors such as loud noises, separation from their owners, or changes in their environment. CBD may help reduce anxiety levels by promoting a sense of calm.

 

 

 

 

 

 

Choosing the Right CBD Treats

 

When selecting CBD treats for your dog, it’s essential to look beyond just the CBD content. The overall quality of the treat is equally important. Here are some key ingredients you should be aware of:

 

1. High-Quality CBD Oil

 

The foundation of any good CBD treat is the quality of the CBD oil used. Look for treats that contain:

 

  • Full-Spectrum or Broad-Spectrum CBD: Full-spectrum products contain all cannabinoids found in the hemp plant, including trace amounts of THC (below 0.3% as per legal standards). Broad-spectrum products contain multiple cannabinoids but no THC. Both types can provide an “entourage effect,” enhancing the therapeutic benefits.

 

 

 

2. Natural Ingredients

 

Just like human food, the ingredients in your dog’s treats matter significantly. Look for treats made with natural ingredients rather than artificial additives or preservatives. Here are some beneficial components:

 

Whole grains like oat flour or brown rice flour provide essential nutrients and fiber that support digestive health. They are also a good source of energy for active dogs.

 

Healthy fats are vital for maintaining your dog’s coat and skin health. Ingredients like coconut oil or peanut butter not only enhance flavor but also provide beneficial fatty acids that support overall well-being.

 

Incorporating fruits and vegetables into your dog’s treats can boost their nutritional value:

 

 

 

 

 

To make treats more appealing without resorting to artificial flavors, look for natural flavorings like chicken broth or carob (a chocolate substitute safe for dogs). These ingredients can enhance taste while keeping the treat healthy.

 

3. Functional Ingredients

 

Some treats may include additional functional ingredients designed to address specific health concerns:

 

 

These compounds are often included in joint support treats to help maintain joint health and mobility, especially in older dogs or those with arthritis.

 

 

Probiotics can promote gut health by supporting a healthy balance of bacteria in your dog’s digestive system.

 

 

Certain herbs like chamomile or ginger may offer calming effects or aid digestion. Always ensure these herbs are safe for canine consumption before choosing treats containing them.

 

Ingredients to Avoid

 

While there are many beneficial ingredients to seek out, it’s equally important to know which ones to avoid:

 

1. Artificial Additives

 

Many commercial pet treats contain artificial colors, flavors, and preservatives that can be harmful to your dog’s health. These additives may lead to allergic reactions or other health issues over time.

 

2. High Sugar Content

 

Just like humans, dogs do not need excessive sugar in their diets. Treats high in sugar can lead to obesity and dental problems.

 

3. Low-Quality Fillers

 

Avoid treats with low-quality fillers such as corn syrup or by-products that do not provide any nutritional value.

 

4. THC (Tetrahydrocannabinol)

Always ensure that any CBD product you choose contains less than 0.3% THC to avoid any psychoactive effects on your dog.

 

How to Introduce CBD Treats Safely

 

When introducing any new treat into your dog’s diet—especially one containing CBD—it’s essential to do so gradually:

 

  • Start Small: Begin with a small amount of the treat to see how your dog reacts.

  • Monitor Your Dog: Observe your dog for any adverse reactions such as changes in behavior or gastrointestinal upset.

  • Adjust Dosage as Needed: Depending on your dog’s size and needs, you may need to adjust the dosage over time.

  • Consult Your Veterinarian: Before starting any new supplement regimen, including CBD treats, consult with your veterinarian—especially if your dog has existing health conditions or is taking other medications.

 

Conclusion

 

CBD treats can be a beneficial addition to your dog’s diet when chosen carefully with attention to ingredient quality and safety. By understanding what goes into these treats—such as high-quality CBD oil, natural ingredients, functional additives—and knowing what to avoid, you can make informed decisions that support your dog’s health and well-being.

Always prioritize transparency from manufacturers regarding ingredient sourcing and product testing; this will ensure you’re providing your furry friend with safe and effective options tailored to their needs. With proper research and guidance from a veterinarian, you can confidently explore the potential benefits of CBD treats for your beloved pet while ensuring they enjoy a tasty snack that’s good for them too!

 

CBD OIL FOR DOGS, READ ON…

CAN CBD OIL HELP DOGS

WHAT CONDITIONS CAN CBD HELP TREAT IT DOGS?



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media